HemaSphere
(Jun 2022)
P344: THE DUAL BCL-2 AND BCL-XL INHIBITOR AZD4320 SHOWS ON-TARGET ACTIVITY IN ALL AND ACTS SYNERGISTICALLY WITH MCL-1 INHIBITION
- M. C. Wichert,
- A. Niedermayer,
- S. Enzenmüller,
- K.-M. Debatin,
- L. H. Meyer,
- F. Seyfried
Affiliations
- M. C. Wichert
- 1 Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany
- A. Niedermayer
- 1 Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany
- S. Enzenmüller
- 1 Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany
- K.-M. Debatin
- 1 Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany
- L. H. Meyer
- 1 Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany
- F. Seyfried
- 1 Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany
- DOI
-
https://doi.org/10.1097/01.HS9.0000844264.32857.90
- Journal volume & issue
-
Vol. 6
pp.
244
– 245
WeChat QR code